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ABSTRACT
Objective: Lansoprazole (LPZ) is a Biopharmaceutics Classification System Class II drug. It has low solubility and high permeability, so its rate of 
dissolution is a rate-limiting step for drug absorption. This study aimed to improve the dissolution rate of LPZ by forming cocrystals, using nicotinamide 
(NCT) as the conformer.
Methods: Cocrystals of LPZ were produced using the solvent evaporation and solvent-drop grinding methods with a molar ratio of 1:1 and 1:2. 
The cocrystals were characterized using Fourier-transform infrared spectroscopy (FTIR), X-ray powder diffraction (XRD), and differential scanning 
calorimetry (DSC). The solubility and dissolution of the LPZ cocrystals were examined in distilled water.
Results: FTIR was used to confirm the formation of hydrogen bonds between LPZ and NCT. DSC and XRD studies showed the formation of crystals 
from cocrystals and a decrease of the melting point of the cocrystals. The dissolution study revealed that the cocrystals could increase the LPZ 
dissolution rate by up to 8.4-fold compared with pure LPZ.
Conclusion: LPZ cocrystal formation with NCT was successful in increasing the dissolution rate of LPZ.
Keywords: Lansoprazole, Nicotinamide, Cocrystals, Dissolution rate.
INTRODUCTION
Most active pharmaceutical ingredients have either poor solubility or 
poor permeability, or both. The bioavailability of orally administered 
drugs depends strongly on the drug’s solubility in aqueous medium, 
so the solubility behavior of drugs is one of the most challenging tasks 
in the design of oral dosage. In drugs with poor water solubility, low 
bioavailability is often observed after oral administration since in vivo 
dissolution of a drug can be a rate-limiting step [1,2].
Lansoprazole (LPZ) {2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-
pyridinyl] methyl sulfinyl-1H-benzimidazole} is a proton-pump 
inhibitor that acts on membrane H+/K+ -ATPase in gastric parietal 
cells. It is widely used to treat a variety of acid-related disorders, 
including peptic ulcers, both duodenal and gastric, symptoms of 
gastroesophageal reflux disease, erosive esophagitis, drug-induced 
ulcers, and hypersecretory syndromes, such as Zollinger–Ellison and 
Helicobacter pylori infections [3,4]. LPZ is a Class II drug under the 
Biopharmaceutics Classification System. These drugs are characterized 
by high permeability, but poor solubility. Therefore, increasing the 
rate of dissolution of LPZ is paramount to increase the rate of drug 
absorption [5,6].
One way to improve drug solubility is through cocrystallization, a 
method which involves the modification of a crystalline drug substance 
by the addition of a coformer. Cocrystallization can improve the 
solubility, dissolution rate, bioavailability, and stability of an active 
substance. The methods used for cocrystallization include the solvent 
and grinding methods [7].
Many ways of producing cocrystals have been reported. The most 
common methods are based on solution and grinding. The dilution 
method involves mixing the two components comprising the active 
ingredient of the drug and the coformer in a solvent or mixture of 
solvents. Dissolution includes several methods, such as evaporation, 
reaction crystallization, and cooling. Dilution is used in many cocrystal 
formations, but the process requires a considerable amount of 
solvent [7,8]. Grinding methods consist of mixing the stoichiometric 
cocrystal components and grinding them either manually, using a 
mortar and pestle, or mechanically, using a ball mill or a vibratory 
mill [8]. There are two different techniques for cocrystal formation using 
grinding methods, namely, dry grinding and solvent-drop grinding.
In this research, cocrystals of LPZ using nicotinamide (NCT) as the 
coformer were produced using the solvent evaporation and solvent-
drop grinding methods. NCT is highly soluble in water, which should 
increase the rate of dissolution of LPZ [9,10]. Cocrystals produced in this 
way should have better solubility, increasing the bioavailability of LPZ. 
Dissolution tests were conducted on pure LPZ and the cocrystals of LPZ-
NCT. The cocrystals were characterized by infrared spectroscopy, X-ray 
powder diffraction (XRD), and differential scanning calorimetry (DSC).
METHODS
Materials
LPZ was kindly provided by PT Clinisindo, Indonesia (Cipla, India). 
NCT and methanol were purchased from Brataco, Indonesia. Double-
distilled water was purchased from Ikapharmindo, Indonesia.
Preparation of cocrystals of LPZ-NCT using the solvent evaporation 
method
LPZ and NCT at a molar ratio of 1:1 and 1:2 were dissolved in methanol 
by stirring. The solvent was evaporated and the residue dried at room 
temperature. The mixture was stored in a desiccator [11].
Preparation of cocrystals of LPZ-NCT using solvent-drop grinding 
method
A required amount of LPZ and NCT with a molar ratio of 1:1 and 1:2 
was placed in a ball mill. Methanol was then added. The mixture was 
evaporated at room temperature and stored in a desiccator [11].
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Preparation of a physical mixture of LPZ-NCT
A mixture of LPZ and NCT was produced with a molar ratio of 1:2. The 
mixture was placed in a mortar, homogenized with a spatula, and then 
stored in a desiccator.
Determination of LPZ content
The LPZ content was determined by weighing a specified amount of 
the LPZ-NCT cocrystals in a volumetric flask, dissolving it in methanol, 
and filling it to the desired volume with double-distilled water. The 
samples were then assayed using an ultraviolet–visible (UV–VIS) 
spectrophotometer at a wavelength of 283 nm [12].
Characterization of cocrystals
Crystal form
The crystal forms of the LPZ-NCT cocrystals and LPZ and NCT were 
observed through polarization microscopy. Samples were placed on a 
slide, covered with a cover glass, and observed at a microscope under 
×400–1000.
Fourier-transform infrared (FTIR) spectroscopy
The LPZ-NCT cocrystals were analyzed using FTIR (Shimadzu 8400S, 
Japan) by mixing KBr in a mortar. The wavelength analyzed was 400–
4000 cm−1, and characteristic peaks were recorded [4].
XRD
X-ray patterns of the LPZ-NCT cocrystals were recorded using an X-ray 
diffractometer with Cu as the anode material, at a voltage of 40 kV and 
a current of 40 mA. The samples were analyzed at angles 2θ of 2–30°C 
at scan rates of 1°C/min [4].
DSC
DSC measurements were performed using a PerkinElmer type 600 
setup. The samples of the LPZ-NCT cocrystals and the pure LPZ (2.5–
5 mg) were hermetically sealed in aluminum pans and heated at a 
constant rate of 10°C/min within a temperature range of 25–250°C, 
with a flow rate of 20 mL/min using nitrogen gas [4].
Saturated solubility
To determine the saturated solubility of the LPZ-NCT cocrystals, 
approximately 50 mg of the LPZ-NCT cocrystals were weighed and 
added to 100 mL of double-distilled water, and the resulting slurries 
were stirred on a magnetic stirrer at 25±0.5°C. An aliquot of the 
slurry was double filtered at 0.45 µm. The diluted samples were 
then assayed using a UV–VIS spectrophotometer at a wavelength of 
283 nm.
Dissolution study
The dissolution tests were conducted using a USP type II apparatus to 
determine the initial dissolution rate of the LPZ-NCT cocrystals. The 
LPZ-NCT cocrystals, the LPZ and NCT physical mixture, and the pure 
LPZ were weighed equivalent to 50 mg of LPZ. The dissolution test was 
performed at 37±0.5°C for 1 h using double-distilled water. Then, 5 mL 
aliquots were withdrawn at 5, 10, 15, 20, 25, 30, 40, 50, and 60 min 
and replaced with an equivalent amount of fresh medium to maintain 
the sink condition and analyzed using a UV–VIS spectrophotometer at a 
wavelength of 283 nm.
RESULTS AND DISCUSSION
Determination of drug content
Table 1 shows the yield value and LPZ content in the LPZ-NCT cocrystals. 
The results showed that the LPZ cocrystals produced using the solvent 
evaporation method with the ratios of 1:1 and 1:2 containing 75.08% 
and 58.98% LPZ, respectively. The cocrystals of LPZ produced using 
the solvent-drop grinding method with molar ratios of 1:1 and 1:2 
containing 71.16% and 55.47% LPZ, respectively. Some loss of LPZ in 
cocrystals may occur during the process.
Characterization of cocrystals
Crystal form
Macroscopically, the cocrystals produced using the solvent evaporation 
method were in the form of a greenish-brown crystalline powder. The 
cocrystals produced using the solvent-drop grinding method were 
brown crystalline powder. The powder produced using the solvent-
drop grinding method was finer than that of cocrystals produced using 
the solvent evaporation method.
Microscopically, there were different crystalline forms of cocrystals, 
as shown in Fig. 1. The cocrystals produced using the solvent 
evaporation method had a crystalline form like a diamond. The 
cocrystals produced using the solvent-drop grinding method, 
however, had an irregular crystalline form. The cocrystals produced 
using the solvent evaporation method had a more crystalline 
form than that of cocrystals produced using the solvent-drop 
grinding method. The differences in crystal form were due to 
Fig. 2: Possible hydrogen bonding between lansoprazole and 
nicotinamide
Table 1: Yield value and LPZ content in the LPZ-NCT cocrystals














LZP: Lansoprazole, NCT: Nicotinamide
Fig. 1: Microscopic crystalline forms of the lansoprazole (LPZ)-
nicotinamide (NCT) cocrystals produced using (a) the solvent 
evaporation (SE) method with a molar ratio of 1:1, (b) SE with 
a molar ratio of 1:2, (c) physical mixture of LPZ-NCT, (d) the 
solvent-drop grinding (SDG) method with a molar ratio of 1:1, 
(e) SDG with a molar ratio of 1:2, and (f) the pure LPZ; ×1000
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the manufacturing method, in which the solvent-drop grinding 
and milling processes are carried out at a constant speed using a 
vibrating mill. This leads to the production of a crystalline form 
which is smaller than the crystals produced using the solvent 
evaporation method [13].
FTIR
Interactions between the substances occur through hydrogen bonding 
between LPZ and NCT. A hypothetical possibility of hydrogen bonding 
of the cocrystals of LPZ is shown in Fig. 2.
The FTIR spectra of cocrystals produced using all of the methods, 
for LPZ, NCT, and physical mixtures between LPZ-NCT, are presented 
in Fig. 3. The characteristic absorption of cocrystals shows peaks at 
1398.44 to 1402.30 cm−1 denoting hydrogen bonds between S=O of 
LPZ and atom H from the amide group of NCT. The FTIR spectra show 
shifting peaks between the atom four of LPZ and atom H from the amide 
group of NCT at 1402.30 to 1398.44 cm−1. In addition, there are new 
wavelengths between 1697.41 and 1681.98 cm−1.
Based on the observed wavelengths of the FTIR spectrum of cocrystals 
of LPZ, it can be concluded that the manufacture of cocrystals of LPZ 
and NCT resulted from hydrogen bonding between LPZ and NCT.
X-ray diffraction (XRD)
Fig. 4 shows a diffractogram of LPZ cocrystals, prepared through the 
solvent evaporation method, with molar ratios of 1:1 and 1:2. The results 
represent an increase in intensity compared with pure LPZ, indicating 
changes or additions to the form and structure of the crystal grid on 
cocrystals. The diffractograms of the cocrystals from solvent-drop grinding 
methods showed a decrease in intensity compared with diffractograms of 
pure LPZ. This is because the solvent-drop grinding method causes particle 
size reduction by milling at high speed. Diffractogram intensity has also 
increased, indicating the formation of crystals in cocrystals of LPZ [4].
DSC
Thermograms of the LPZ-NCT cocrystals are shown in Fig. 5. The LPZ-
NCT cocrystals have a lower melting point than pure LPZ. This finding 
Fig. 3: Fourier transform infrared spectra of (a) lansoprazole (LPZ), (b) physical mixture of LPZ-nicotinamide (NCT), (c) NCT, and (d) the 
LPZ-NCT cocrystals (1:2)
Fig. 4: Multiplot diffractograms of the pure lansoprazole (LPZ) (top), the LPZ-nicotinamide (NCT) cocrystals produced using the solvent 
evaporation method with a molar ratio of 1:2 (middle), and the LPZ-NCT cocrystals produced using the solvent-drop grinding method 
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indicates that there has been an interaction between LPZ and NCT. 
The thermogram results indicate that pure LPZ has a melting point of 
170.52°C. Cocrystals produced using the solvent-drop grinding method 
with a molar ratio of 1:2 showed a decreased melting point compared 
with pure LPZ, at a temperature of 123.27°C. Cocrystals from the solvent 
evaporation method with a molar ratio of 1:2 showed a decrease of 
melting point to 124.38°C, and the physical mixture of LPZ-NCT has a 
melting point of 129.51°C.
Characterization using DSC showed that fusion energy is needed to melt 
a sample of cocrystal. The thermogram showed an increase in fusion 
energy over pure LPZ. The energy required to melt the cocrystal was 
greater than that required to melt pure LPZ [10,13].
Solubility
Cocrystals of LPZ exhibited increased solubility compared with LPZ, 
as shown in Fig. 6. The solubility of cocrystals produced using the 
solvent evaporation method with a molar ratio of 1:1 was increased 
by 1.1-fold, and that for a molar ratio of 1:2 was increased by 1.37-
fold compared with pure LPZ. Similarly, the solubility of cocrystals 
produced using the solvent-drop grinding method at a molar ratio 
of 1:1 was increased by 1.7-fold, and that for a molar ratio of 1:2 
was increased by 2.28-fold, whereas the physical mixture between 
LPZ and NCT with a molar ratio of 1:2 was increased by 1.25-fold 
compared with pure LPZ.
Cocrystals produced using the solvent-drop grinding method with a 
molar ratio of 1:2 had the highest increase in solubility. The increase 
in solubility of cocrystals is due to several mechanisms. The grinding 
process is carried out at high speed, resulting in the reduction of the 
crystalline form of LPZ. NCT is also highly soluble in water, contributing 
to the increased solubility of LPZ [14].
From the results of the saturated solubility tests, it appears that 
cocrystals produced using all methods and the physical mixture 
of LPZ-NCT showed an increase in solubility when compared with 
pure LPZ.
Dissolution study
Fig. 7 shows the dissolution profiles of the LPZ-NCT cocrystals, which 
revealed that the percentage of dissolved LPZ from the LPZ-NCT 
cocrystals produced using the solvent-drop grinding method with a 
molar ratio of 1:2 was increased by 8.4-fold when compared with pure 
LPZ. The solubility of cocrystals from the same method with a molar 
ratio of 1:1 increased in 5 min the amount of dissolved drug by 6.58-
fold. Cocrystals produced using the solvent evaporation method with a 
molar ratio of 1:1 increased by 6.33-fold in 5 min and for a molar ratio 































Fig. 6: Solubility of the lansoprazole-nicotinamide cocrystals 
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Fig. 7: The dissolution profile of the lansoprazole-nicotinamide 
cocrystals in distilled water at 37±0.5°C for 1 h; each point 
represents the mean±standard deviation; n=3
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of 1:2, 7.4-fold. On the other hand, the physical mixture of LPZ-NCT with 
a molar ratio of 1:2 was increased by 3.87-fold compared with pure LPZ.
The increase in the cumulative amount of LPZ dissolved was apparent 
in 60 min. The percentage of cocrystals produced using the solvent-
drop grinding method with a molar ratio of 1:2 showed the greatest 
improvement, in which the 60 min increase was 1.48-fold, and a molar 
ratio of 1:1 was increased by 1.44-fold. Cocrystals produced using the 
solvent evaporation method with a molar ratio of 1:1 increased by 1.07-
fold, and that for a molar ratio of 1:2 was increased by 1.32-fold. The 
physical mixture between LPZ and NCT with a molar ratio of 1:2 was 
increased by 1.26-fold when compared with pure LPZ.
Based on the results of the dissolution test, it appears that the 
cocrystals of LPZ using NCT as a coformer increase the dissolution of 
LPZ in water due to the hydrogen bonds in the cocrystals of LPZ. These 
hydrogen bonds can improve the dissolution of the cocrystals [15]. The 
increasing dissolution of cocrystals caused by the grinding process is 
carried out at high speed in the solvent-drop grinding method. NCT is 
highly soluble in water, contributing to the increased dissolution rate 
of LPZ.
CONCLUSION
The formation of the cocrystals of LPZ using NCT as coformer with 
a molar ratio of 1:1 and 1:2 using the solvent evaporation and 
solvent-drop grinding methods was confirmed by the presence of 
hydrogen bonding in the infrared spectrum, the addition of a crystal 
grid on X-ray diffraction, and a decline in the melting point in the 
thermal analysis. Moreover, the LPZ-NCT cocrystals produced using 
the solvent-drop grinding method with a molar ratio of 1:2 showed 
the greatest increase in solubility in water. The LPZ-NCT cocrystals 
produced using the solvent-drop grinding method had the highest 
dissolution rate within 5 min, and it was an increase of 8.4-fold 
compared with pure LPZ.
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